These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25062735)

  • 1. Depressed mood and suicidality in individuals exposed to tetrabenazine in a large Huntington disease observational study.
    Dorsey ER; Brocht AF; Nichols PE; Darwin KC; Anderson KE; Beck CA; Singh S; Biglan KM; Shoulson I
    J Huntingtons Dis; 2013; 2(4):509-15. PubMed ID: 25062735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrabenazine and suicidal ideation.
    Shahani L
    J Neuropsychiatry Clin Neurosci; 2013; 25(1):E30. PubMed ID: 23487220
    [No Abstract]   [Full Text] [Related]  

  • 3. Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.
    McGarry A; McDermott MP; Kieburtz K; Fung WLA; McCusker E; Peng J; de Blieck EA; Cudkowicz M;
    Neurology; 2019 Apr; 92(14):e1643-e1651. PubMed ID: 30850442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrabenazine, depression and suicide: good news.
    Margolis RL
    J Huntingtons Dis; 2014; 3(2):137-8. PubMed ID: 25062856
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluating depression and suicidality in tetrabenazine users with Huntington disease.
    Schultz JL; Killoran A; Nopoulos PC; Chabal CC; Moser DJ; Kamholz JA
    Neurology; 2018 Jul; 91(3):e202-e207. PubMed ID: 29925548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suicidality in Huntington's disease.
    Hubers AA; Reedeker N; Giltay EJ; Roos RA; van Duijn E; van der Mast RC
    J Affect Disord; 2012 Feb; 136(3):550-7. PubMed ID: 22119091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidal ideation in a European Huntington's disease population.
    Hubers AA; van Duijn E; Roos RA; Craufurd D; Rickards H; Bernhard Landwehrmeyer G; van der Mast RC; Giltay EJ;
    J Affect Disord; 2013 Oct; 151(1):248-58. PubMed ID: 23876196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.
    Frank S
    BMC Neurol; 2009 Dec; 9():62. PubMed ID: 20021666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive Syndrome Associated With Tetrabenazine in Huntington Disease: A Case Report.
    Palermo G; Mazzucchi S; Unti E; Bonuccelli U; Ceravolo R
    J Clin Psychopharmacol; 2020; 40(6):628-630. PubMed ID: 33136925
    [No Abstract]   [Full Text] [Related]  

  • 10. Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature.
    Chen JJ; Ondo WG; Dashtipour K; Swope DM
    Clin Ther; 2012 Jul; 34(7):1487-504. PubMed ID: 22749259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tetrabenazine (tetrabenazine Orphan) orally].
    J Pharm Belg; 2014 Dec; (4):49-50. PubMed ID: 25562927
    [No Abstract]   [Full Text] [Related]  

  • 12. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders.
    Guay DR
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial.
    Huntington Study Group
    Neurology; 2006 Feb; 66(3):366-72. PubMed ID: 16476934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of deutetrabenazine: a novel treatment for chorea associated with Huntington's disease.
    Dean M; Sung VW
    Drug Des Devel Ther; 2018; 12():313-319. PubMed ID: 29497277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suicidal Ideation Assessment in Individuals with Premanifest and Manifest Huntington Disease.
    Wesson M; Boileau NR; Perlmutter JS; Paulsen JS; Barton SK; McCormack MK; Carlozzi NE
    J Huntingtons Dis; 2018; 7(3):239-249. PubMed ID: 30056431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suicidal ideation and suicide attempts among adults with psychotic experiences: data from the Collaborative Psychiatric Epidemiology Surveys.
    DeVylder JE; Lukens EP; Link BG; Lieberman JA
    JAMA Psychiatry; 2015 Mar; 72(3):219-25. PubMed ID: 25715312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrabenazine (Xenazine) for Huntington's chorea.
    Med Lett Drugs Ther; 2009 Jan; 51(1304):7-8. PubMed ID: 19172140
    [No Abstract]   [Full Text] [Related]  

  • 18. Panic as an independent risk factor for suicide attempt in depressive illness: findings from the National Epidemiological Survey on Alcohol and Related Conditions (NESARC).
    Katz C; Yaseen ZS; Mojtabai R; Cohen LJ; Galynker II
    J Clin Psychiatry; 2011 Dec; 72(12):1628-35. PubMed ID: 21457675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suicidal ideation in Huntington disease: the role of comorbidity.
    Wetzel HH; Gehl CR; Dellefave-Castillo L; Schiffman JF; Shannon KM; Paulsen JS;
    Psychiatry Res; 2011 Aug; 188(3):372-6. PubMed ID: 21605914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effect of tetrabenazine in the management of Huntington disease.
    Fasano A; Cadeddu F; Guidubaldi A; Piano C; Soleti F; Zinzi P; Bentivoglio AR
    Clin Neuropharmacol; 2008; 31(6):313-8. PubMed ID: 19050408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.